Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for Gastric Visualization in Acute UGIB
NCT04771481Phase 4Completed
- Start
- Apr 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute upper gastrointestinal bleeding (UGIB) comparing Metoclopramide with Placebo (2 arms). Primary endpoint: Percentage of patients with 'adequate visualization'. Started Apr 2021; status: completed.
02
Drugs
metoclopramide
03
Conditions
acute upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT04771481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771481.